Mural Oncology Price To Sales Ratio Over Time
| MURA Stock | 3.63 0.01 0.28% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Mural Oncology Performance and Mural Oncology Correlation. Mural |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mural Oncology. If investors know Mural will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mural Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Mural Oncology plc is measured differently than its book value, which is the value of Mural that is recorded on the company's balance sheet. Investors also form their own opinion of Mural Oncology's value that differs from its market value or its book value, called intrinsic value, which is Mural Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mural Oncology's market value can be influenced by many factors that don't directly affect Mural Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mural Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mural Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mural Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Price To Sales Ratio Analysis
Compare Mural Oncology plc and related stocks such as Coeur Mining, United Microelectronics, and Rambler Metals Price To Sales Ratio Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CDE | 16.5625 | 2.1129 | 2.4569 | 1.4229 | 0.8231 | 0.4976 | 2.1825 | 1.9035 | 1.3447 | 2.4849 | 3.1731 | 1.5132 | 1.1769 | 1.3619 | 2.1373 | 3.65 |
| UMC | 11.871 | 1.367 | 1.2714 | 1.2315 | 1.2994 | 1.0307 | 0.9328 | 1.1409 | 0.9392 | 1.3081 | 3.2193 | 3.7284 | 1.797 | 2.8852 | 3.32 | 3.01 |
| KLAC | 3.7187 | 2.5898 | 3.2297 | 4.1167 | 3.2415 | 3.8256 | 4.1145 | 3.9711 | 4.1574 | 5.2517 | 7.2204 | 5.2128 | 6.4455 | 11.4181 | 10.28 | 10.79 |
| CRUS | 1.1399 | 2.4715 | 2.4715 | 2.4715 | 2.4715 | 2.4715 | 2.4715 | 3.0946 | 3.0946 | 3.0946 | 3.0946 | 3.0946 | 3.0946 | 2.8091 | 1.6814 | 2.95 |
| MX | 0.4885 | 0.3753 | 0.7103 | 0.9358 | 0.6336 | 0.2868 | 0.3139 | 0.4969 | 0.2842 | 0.503 | 0.9389 | 1.9845 | 1.2473 | 1.3371 | 1.2 | 0.62 |
| ENTG | 2.3518 | 1.5693 | 1.7607 | 2.3223 | 1.9129 | 1.7227 | 2.1489 | 3.2106 | 2.5377 | 4.2544 | 6.9692 | 8.1627 | 2.8437 | 5.0969 | 4.6133 | 4.84 |
Mural Oncology plc and related stocks such as Coeur Mining, United Microelectronics, and Rambler Metals Price To Sales Ratio description
Price to Sales Ratio is figured by comparing Mural Oncology plc stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Mural Oncology sales, a figure that is much harder to manipulate than other Mural Oncology plc multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.My Equities
My Current Equities and Potential Positions
| Mural Oncology plc | MURA |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Ireland |
| Exchange | NASDAQ Exchange |
null 3.46
Check out Mural Oncology Performance and Mural Oncology Correlation. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Mural Oncology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.